Brookhaven Retreat, LLC – Trademark Portfolio
Entity Type: 16
Brookhaven Retreat, LLC holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 10 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include PONCHO, BROOKHAVEN RETREAT, and ALWAYS WEAR YOUR PONCHO LIFE RE-ALIGNMENT PROGRAM. The owner is based in Seymour, TN.
1016 I.C. King Road
Seymour, TN 37865
Showing of trademarks Trademarks
Trademark Classifications
Brookhaven Retreat, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Brookhaven Retreat, LLC have?
Brookhaven Retreat, LLC has 16 U.S. trademarks filed with the USPTO. Of these, 6 registered, 7 abandoned, 3 cancelled.
What trademark classes does Brookhaven Retreat, LLC file in?
Brookhaven Retreat, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 16 (Paper Goods). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Brookhaven Retreat, LLC's most well-known trademarks?
Brookhaven Retreat, LLC's registered trademark portfolio includes well-known marks such as PONCHO, BROOKHAVEN RETREAT, and ALWAYS WEAR YOUR PONCHO LIFE RE-ALIGNMENT PROGRAM. These are among 6 currently registered trademarks in the portfolio.
What is Brookhaven Retreat, LLC's trademark registration success rate?
Brookhaven Retreat, LLC has a 38% trademark registration rate, with 6 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.